J. Bio. Env. Sci.11(4), 37-47, October 2017
Understanding the chemical composition of some plants helps us to provide better treatments with fewer side effects. Examining the chemical structure of these plants, for example, is effective in improving the treatment of depression: “Milkweed”, “Valeriana officinalis”, “Citrus aurantium”, “Avena sativa”, “Ocimum basilicum”, “Echium”, “Hypericum perforatum”, “Rosa”, “Crocus sativus”, “Crocus sativus”, “Dracocephalum”, “Lavandula”, “Papaver”, “Matricaria chamomilla”, “Rosmarinus officinalis”, ‘Hypericum perforatum”. Multiple human clinical trials provide preliminary positive evidence of antidepressant efficacy (Echium amoenum, Crocus sativus and Rhodiola rosea) and anxiolytic activity (Matricaria recutita, Ginkgo biloba, Passiflora incanata, E. ammonium and Scutellaria lateriflora). In all these plants, flavonoids inhibit the efficacy of the plant against neurode generative diseases and depression. There are other factors as well as play a role in the efficacy. Among these factors include: Fntylamyn in sour orange and synephrine, alkaloids, phenols, serotonin, terpenes and monoterpenes, lignans, linalool, anthocyanins, barbiturates and benzodiazepines on a milk weed plant.
Abdullaev FI. 2002. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Experimental Biology and Medicine 227, 20–5.
Abe K, Saito H. 2000. Effects of saffon and its constituent crocin on learning behavior and long-term potentiation. Phytotherapy Research; 14, 149–52.
Akhondzadeh S, Kashani L, Fotouhi A, Jarvandi S, Mobaseri M, Moin M. 2003. Comparison of Lavandula angustifolia Mill. Tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Progress in Neuro-Psychopharmacology; 27(1):123–7. http://dx.doi.org/10.1016/S0278-5846(02)00342-1.
Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. 2009. A randomized, double-blind, placebocontrolled, trial of oral Matricaria recutita (Chamomile) extract therapy of generalized anxiety disorder. Journal of Clinical Psychopharmacology; 29, 378–382.
Archived Copy. 2016. Archived from the original on 31 March. Retrieved 2015-10-19. Hypericum perforatum.
Bittar M, deSouza MM, Yunus RA, Lento R, Monache FD, Cechinel VF. 2000. Antinociceptive Activity of me-3, II8-binarigenin, a biflavonoid present in plants of the guttiferae. Planta Medica; 66, 84–6.
Bora KS, Arora S, Shri R. 2011. Role of Ocimum basilicum L. in prevention of ischemia and reperfusion-inducedcerebral damage, and motor dysfunctions in mice brain. Journal of Ethnopharmacology; 137, 1360–1365.
Boskabady MH, Shafei MN, Saberi Z, Amini S. 2011. Pharmacological Effects of Rosa Damascena. Iranian Journal of Basic Medical Sciences; 14 (4): 213-218.
Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J. 2002. In vitro receptor screening of pure constituents of St. John’s wort reveals novel interactions with a number of GPCRs. Psychopharmacology (Berl); 162, 193-202.
Cavanagh HM, Wilkinson JM. 2002. Biological activities of lavender essential oil. Phytotherapy Research; 16(4), 301–8. doi: 10.1002/ptr.1103. [PubMed] [Cross Ref].
Chemical Information Review Document for Valerian (Valeriana officinalis).11/2009.
Chu Y. 2014. Oats nutrition and technology. 1. (1 edition). Wiley Blacwell.
Clark WG, Brater DC, Johnscn AR. 1989. Goth’s medical pharmacology. 12th ed. New Delhi: Galgotia Publication Pvt. Ltd, 288.
Denner SS. 2009. Lavandula angustifolia Miller: English lavender. Holistic Nursing Practice 23(1), 57–64. 0. fc. [PubMed] [Cross Ref] http://dx.doi.org/10.1097/01.HNP.0000343210.5671
Enzymes. 30 June 2013. Retrieved 12 December 2014. Hyperforin. Human Metabolome Database. 3.6. University of Alberta.
Evans WC. 1996. Trease and Evans-Pharmacognosy. China: Saunders© Elsevier Limited. p. 438.